Latest Form 4 insider transactions

Steven F. Urvan, Chief Executive Officer, a Director and 10% owner of Ammo, Inc., reported multiple transactions in common stock on May 30, 2025.

Adil Engineer, Chief Operating Officer of Aehr Test Systems, reported a transaction in 500 shares of common stock on August 14, 2026.

8 Rivers Capital, LLC and 1 other reported changes in beneficial ownership of NET Power Inc. common stock on August 12, 2026.

Sonalee Elizabeth Parekh, a Director of indie Semiconductor, Inc., sold 20,000 shares of common stock on August 12, 2026 for $3.80 per share.

Gary A Simanson and 1 other reported changes in beneficial ownership of Thunder Bridge Capital Partners V, Ltd. common stock on August 12, 2026.

Thurgood Marshall Jr, a Director of CoreCivic, Inc., sold 7,100 shares of common stock on August 13, 2026 for $34.00 per share.

Joseph D Mansueto, Executive Chairman, a Director and 10% owner of Morningstar, Inc., sold 14,500 shares of common stock on August 13, 2026.

Anthony Mathew Eisen, a Director of Block, Inc., sold 18,000 shares of common stock on August 12, 2026.

Roberto R Herencia, CHIEF EXECUTIVE OFFICER and a Director of Byline Bancorp, Inc., sold 19,750 shares of common stock on August 13, 2026 for $39.21 per share.

John R Prann Jr, a Director of CoreCivic, Inc., sold 30,000 shares of common stock on August 14, 2026 for $32.21 per share.

Anthony L Grande, EVP, Chief Development Officer of CoreCivic, Inc., sold 801 shares of common stock on August 13, 2026 for $34.00 per share.

Howard T Slayen, a Director of Aehr Test Systems, sold 5,700 shares of common stock on August 14, 2026 for $133.03 per share.

Didier H. Lasserre, a Director of Gsi Technology Inc, received 40,000 shares of common stock on August 13, 2026.

Paul T Quinlan, General Counsel of Oruka Therapeutics, Inc., sold 52,000 shares of common stock on August 14, 2026.

Harley G. Lappin, a Director of CoreCivic, Inc., sold 25,032 shares of common stock on August 13, 2026.

Joseph Keough, a Director of Interface Inc, reported a transaction in 8,442 shares of common stock on August 13, 2026.

Teresa Deluca, a Director of LifeStance Health Group, Inc., sold 20,441 shares of common stock on August 13, 2026 for $12.23 per share.

Barbara Trebbi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Velchamy Sankarlingam, Pres. of Engineering & Product of Zoom Communications, Inc., sold 7,644 shares of common stock on July 15, 2026 for $91.98 per share.

Sam Levinson, a Director and 10% owner of Clipper Realty Inc., purchased 154,764 shares of common stock on August 12, 2026.

Rhea J Posedel, a Director of Aehr Test Systems, sold 5,973 shares of common stock on August 14, 2026 for $140.00 per share.

Peter M Castleman, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Third Rock Ventures V, L.P. and 5 others reported changes in beneficial ownership of Septerna, Inc. common stock on August 12, 2026.

T Danny Phillips, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Arjun Agarwal, Senior Vice President, Finance of Oruka Therapeutics, Inc., sold 10,000 shares of common stock on August 13, 2026.

Lloyd Minor, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Joseph E Gilliam, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Sachin Jain, Chief Operating Officer of CoreWeave, Inc., sold 1 shares of common stock on August 12, 2026 for $110.00 per share.

David Paul Fredrickson, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Jeff L Vacirca, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.